Indoco Remedies Limited Asset Resilience Ratio

Latest as of March 2026: 0.77%

Indoco Remedies Limited asset resilience ratio. Indoco Remedies Limited (INDOCO) has an Asset Resilience Ratio of 0.77% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INDOCO days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs199.10 Million

≈ $2.15 Million USD Cash + Short-term Investments

Total Assets

Rs25.93 Billion

≈ $280.45 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Indoco Remedies Limited (2004–2026)

Asset resilience ratio of Indoco Remedies Limited from 2004 to 2026. This chart shows how Indoco Remedies Limited's Asset Resilience Ratio has changed over time. Read Indoco Remedies Limited balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Indoco Remedies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see INDOCO asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs199.10 Million	0.77%
Total Liquid Assets	Rs199.10 Million	0.77%

Asset Resilience Insights

Limited Liquidity: Indoco Remedies Limited maintains only 0.77% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Indoco Remedies Limited Industry Peers by Asset Resilience Ratio

Compare Indoco Remedies Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Enzymatica publ AB ST:ENZY	Drug Manufacturers - Specialty & Generic	22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Indoco Remedies Limited Asset Resilience Ratio by Year (2004–2026)

Indoco Remedies Limited asset resilience ratio by year from 2004 to 2026. The table below shows the annual Asset Resilience Ratio data for Indoco Remedies Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	0.77%	Rs199.10 Million ≈ $2.15 Million	Rs25.93 Billion ≈ $280.45 Million	+0.64pp
2025-03-31	0.13%	Rs32.20 Million ≈ $348.25K	Rs24.30 Billion ≈ $262.79 Million	-0.21pp
2024-03-31	0.34%	Rs72.44 Million ≈ $783.40K	Rs21.45 Billion ≈ $231.94 Million	+0.10pp
2023-03-31	0.24%	Rs39.95 Million ≈ $432.03K	Rs16.58 Billion ≈ $179.33 Million	-1.38pp
2022-03-31	1.63%	Rs241.50 Million ≈ $2.61 Million	Rs14.86 Billion ≈ $160.72 Million	+1.47pp
2021-03-31	0.16%	Rs21.00 Million ≈ $227.15K	Rs13.15 Billion ≈ $142.22 Million	-0.08pp
2020-03-31	0.24%	Rs29.97 Million ≈ $324.16K	Rs12.72 Billion ≈ $137.52 Million	-0.56pp
2019-03-31	0.79%	Rs99.77 Million ≈ $1.08 Million	Rs12.58 Billion ≈ $136.05 Million	+0.65pp
2018-03-31	0.14%	Rs17.49 Million ≈ $189.10K	Rs12.36 Billion ≈ $133.70 Million	-1.15pp
2017-03-31	1.29%	Rs154.38 Million ≈ $1.67 Million	Rs11.97 Billion ≈ $129.45 Million	-0.29pp
2016-03-31	1.58%	Rs152.08 Million ≈ $1.64 Million	Rs9.64 Billion ≈ $104.23 Million	-6.62pp
2013-03-31	8.20%	Rs565.32 Million ≈ $6.11 Million	Rs6.89 Billion ≈ $74.55 Million	-4.04pp
2011-03-31	12.24%	Rs691.28 Million ≈ $7.48 Million	Rs5.65 Billion ≈ $61.06 Million	+1.07pp
2010-03-31	11.17%	Rs535.20 Million ≈ $5.79 Million	Rs4.79 Billion ≈ $51.81 Million	+1.19pp
2009-03-31	9.99%	Rs415.14 Million ≈ $4.49 Million	Rs4.16 Billion ≈ $44.96 Million	+9.23pp
2008-03-31	0.75%	Rs28.27 Million ≈ $305.73K	Rs3.75 Billion ≈ $40.50 Million	-5.19pp
2007-03-31	5.95%	Rs206.42 Million ≈ $2.23 Million	Rs3.47 Billion ≈ $37.53 Million	+0.88pp
2006-03-31	5.06%	Rs157.33 Million ≈ $1.70 Million	Rs3.11 Billion ≈ $33.60 Million	-0.04pp
2005-03-31	5.10%	Rs145.39 Million ≈ $1.57 Million	Rs2.85 Billion ≈ $30.81 Million	-2.38pp
2004-03-31	7.48%	Rs112.67 Million ≈ $1.22 Million	Rs1.51 Billion ≈ $16.28 Million	--

pp = percentage points

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic

Market Cap

$207.64 Million

Rs19.20 Billion INR

Market Cap Rank

#16205 Global

#823 in India

Share Price

Rs208.30

Change (1 day)

-0.57%

52-Week Range

Rs164.00 - Rs274.85

All Time High

Rs511.66